Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof

• US 5,994,110 A
• Filed: 09/02/1998
• Issued: 11/30/1999
• Est. Priority Date: 02/10/1995
• Status: Expired due to Fees

• Current Assignee: KLAUS MOSBACH, CENTER FOR CHEMISTRY AND CHEMICAL ENGINEERING, PURE AND APPLIED BIOCHEMISTRY
• Original Assignee: Karsten Haupt, Klaus Mosbach, Olof Ramstrom, Peter A.G. Cormack
• Inventors: Cormack, Peter A. G., Mosbach, Klaus, Ramstrom, Olof, Haupt, Karsten
• Primary Examiner(s): KRASS, FREDERICK F
• Application Number:
  US09/145,267
• Time in Patent Office: 454 Days
• Field of Search: 430/8, 427/2.13, 427/2.18, 427/2.31, 427/458, 427/461, 427/466, 427/468, 427/470, 427/471, 427/472, 427/480, 427/481, 427/485, 427/498, 427/504, 427/506, 427/507, 427/508 , 427/510, 427/512, 427/521, 427/551, 427/552, 427/557, 427/559, 435/173.1, 435/173.3, 435/173.4, 435/173.9, 204/157.76, 204/157.77, 204/157.78, 204/157.81, 204/157.82, 204/157.87, 204/157.88, 204/157.92
• US Class Current: 435/173.1
• CPC Class Codes: B01J 20/268 Polymers created by use of a template, e.g. molecularly imprinted polymers
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites

Abstract

Compounds which possess a complementary structure to a desired molecule, such as a biomolecule, in particular polymeric or oligomeric compounds, which are useful as in vivo or in vitro diagnostic and therapeutic agents are provided. Also, various methods for producing such compounds are provided. These polymeric or oligomeric compounds are useful in particular as antimicrobial agents, receptor, hormone or enzyme agonists and antagonists.

Claims

1. A method for producing a molecularly imprinted polymeric compound that exhibits complementary structure to a microbial or mammalian cell or virus comprising the following steps:

(i) immobilizing a microbial or mammalian cell or virus;

(ii) coating said immobilized microbial or mammalian cell or virus with a polymer that is crosslinkable;

(iii) selectively crosslinking the portion of the coating that is proximate to the immobilized mammalian or microbial cell or virus; and

(iv) removing the resultant coating from the microbial or mammalian cell or virus.

2. The method of claim 1, wherein crosslinking occurs upon exposure to light.

3. The method of claim 2, wherein the polymer areas not proximate to the immobilized microbial or mammalian cell or virus are covered with a photomask during photocrosslinking.

4. The method of claim 1, wherein the polymer coating in step (ii) is introduced by a method selected from the group consisting of spray-coating, dip-coating, and spin-coating.

5. The method of claim 1, wherein the resultant coating is suitable for use as a cell separating material or an antimicrobial agent.

6. The method of claim 5, wherein the coating is subsequently cleaved into oligomers.